A detailed history of M&T Bank Corp transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, M&T Bank Corp holds 80,825 shares of WST stock, worth $25.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
80,825
Previous 80,552 0.34%
Holding current value
$25.4 Million
Previous $26.5 Million 8.57%
% of portfolio
0.02%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$277.16 - $333.3 $75,664 - $90,990
273 Added 0.34%
80,825 $24.3 Million
Q2 2024

Jul 31, 2024

SELL
$314.68 - $395.94 $250,170 - $314,772
-795 Reduced 0.98%
80,552 $26.5 Million
Q1 2024

May 07, 2024

BUY
$338.27 - $413.0 $205,668 - $251,104
608 Added 0.75%
81,347 $32.2 Million
Q4 2023

Feb 06, 2024

SELL
$318.29 - $392.21 $328,156 - $404,368
-1,031 Reduced 1.26%
80,739 $28.4 Million
Q3 2023

Nov 02, 2023

BUY
$354.9 - $412.41 $19.3 Million - $22.5 Million
54,472 Added 199.55%
81,770 $30.7 Million
Q2 2023

Aug 09, 2023

SELL
$334.63 - $382.47 $316,559 - $361,816
-946 Reduced 3.35%
27,298 $10.4 Million
Q1 2023

May 11, 2023

SELL
$232.5 - $346.47 $380,835 - $567,517
-1,638 Reduced 5.48%
28,244 $9.79 Million
Q4 2022

Feb 13, 2023

SELL
$209.34 - $261.61 $5.64 Million - $7.05 Million
-26,949 Reduced 47.43%
29,869 $7.03 Million
Q4 2022

Feb 13, 2023

BUY
$209.34 - $261.61 $2,721 - $3,400
13 Added 0.04%
29,882 $7.03 Million
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $305,385 - $426,469
1,241 Added 2.23%
56,818 $13.2 Million
Q2 2022

Aug 05, 2022

SELL
$280.61 - $420.45 $1.3 Million - $1.95 Million
-4,649 Reduced 7.72%
55,577 $15.4 Million
Q1 2022

May 09, 2022

SELL
$357.49 - $445.92 $1.2 Million - $1.5 Million
-3,361 Reduced 5.29%
60,226 $24.7 Million
Q4 2021

Feb 07, 2022

BUY
$402.25 - $471.34 $121,881 - $142,816
303 Added 0.48%
63,587 $29.8 Million
Q3 2021

Oct 28, 2021

BUY
$363.01 - $468.47 $139,032 - $179,424
383 Added 0.61%
63,284 $26.9 Million
Q2 2021

Aug 13, 2021

BUY
$284.77 - $363.2 $72,616 - $92,616
255 Added 0.41%
62,901 $22.6 Million
Q1 2021

May 06, 2021

BUY
$257.29 - $307.53 $99,313 - $118,706
386 Added 0.62%
62,646 $17.7 Million
Q4 2020

Feb 12, 2021

BUY
$261.16 - $301.66 $349,170 - $403,319
1,337 Added 2.19%
62,260 $17.6 Million
Q3 2020

Nov 06, 2020

SELL
$224.99 - $288.02 $279,887 - $358,296
-1,244 Reduced 2.0%
60,923 $16.7 Million
Q2 2020

Jul 29, 2020

BUY
$149.8 - $227.17 $699,116 - $1.06 Million
4,667 Added 8.12%
62,167 $14.1 Million
Q1 2020

May 14, 2020

BUY
$128.96 - $174.76 $330,008 - $447,210
2,559 Added 4.66%
57,500 $8.76 Million
Q4 2019

Feb 07, 2020

SELL
$137.6 - $151.21 $162,092 - $178,125
-1,178 Reduced 2.1%
54,941 $8.26 Million
Q3 2019

Nov 12, 2019

SELL
$121.41 - $150.02 $2.29 Million - $2.82 Million
-18,827 Reduced 25.12%
56,119 $7.96 Million
Q2 2019

Aug 12, 2019

SELL
$111.27 - $125.15 $4,116 - $4,630
-37 Reduced 0.05%
74,946 $9.38 Million
Q1 2019

May 15, 2019

SELL
$94.53 - $110.2 $603,668 - $703,737
-6,386 Reduced 7.85%
74,983 $8.26 Million
Q4 2018

Feb 01, 2019

BUY
$93.0 - $123.98 $140,709 - $187,581
1,513 Added 1.89%
81,369 $7.98 Million
Q3 2018

Nov 09, 2018

SELL
$98.01 - $123.47 $37,929 - $47,782
-387 Reduced 0.48%
79,856 $9.86 Million
Q2 2018

Aug 10, 2018

SELL
$83.32 - $101.88 $127,729 - $156,182
-1,533 Reduced 1.87%
80,243 $7.97 Million
Q1 2018

May 04, 2018

BUY
$85.56 - $102.4 $140,575 - $168,243
1,643 Added 2.05%
81,776 $7.22 Million
Q4 2017

Feb 06, 2018

BUY
$91.65 - $101.65 $1.65 Million - $1.83 Million
17,957 Added 28.88%
80,133 $7.91 Million
Q3 2017

Nov 13, 2017

BUY
$84.54 - $96.75 $10,229 - $11,706
121 Added 0.19%
62,176 $5.99 Million
Q2 2017

Aug 11, 2017

BUY
N/A
62,055
62,055 $5.87 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.